由比古安化物化合物抑制NMDA受体的机制
Arseniy S Zhigulin1, Anastasiya O Novikova1, Oleg I Barygin1
1Sechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 44, Toreza Prospekt, Saint Petersburg 194223, Russia.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2024
概括
比古安化物化合物如循环古安尼尔,普罗古安尼尔和芬福明抑制了N-甲基-D-酸盐 (NMDA) 受体. 这表明治疗与兴奋毒性相关的神经退行性疾病的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- N-甲基-D-酸盐 (NMDA) 受体在突触可塑性和神经元功能中至关重要.
- 对NMDA受体活性的失调与神经退行性疾病有关.
- 最近的药物重用 (胺基,德克斯特罗梅索芬) 强调了NMDA受体对抗剂的治疗潜力.
研究的目的:
- 为了选比古安化化合物对本地NMDA受体的抑制活性.
- 为了研究NMDA受体被活性比古安化物抑制的机制.
- 探索比古安化物作为神经疾病治疗药物的潜力.
主要方法:
- 在大鼠CA1海马体金字塔神经元上的全细胞补丁电生理学.
- 对各种比古安化物化合物的查,包括抗疟疾,低血糖和抗病毒药物.
- 确定IC50值和分析抑制动力学 (竞争性与非竞争性).
主要成果:
- 普罗瓜尼尔,循环瓜尼尔和芬福明在微分子范围内显示出NMDA受体抑制.
- 赛克洛瓜尼尔作为电压依赖的捕获通道阻塞剂.
- 普罗瓜尼尔和芬福明作为全抑制剂起作用.
- 甲胺和摩洛西丁显示了可以忽略不计的NMDA受体活性.
结论:
- 比古安化物表现出NMDA受体对抗性质,具有不同的作用机制.
- 这些发现支持大瓜尼德在神经退行性疾病中的潜在改用.
- 这项研究提供了关于比古安化物-NMDA受体相互作用的结构基础的见解.
相关概念视频
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
181
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
181
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.7K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
01:06Oral Hypoglycemic Agents: Glinides
143
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
143
01:14Antiepileptic Drugs: Glutamate Antagonists
292
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341